Novel Group and CAA are set to exit NuOrder after the business-to-business e-commerce platform agreed to an acquisition by Lightspeed.

SoftBank is set to exit smart scheduling software developer X.ai as its Vision Fund 2 invests in artificial intelligence technology unicorn AInnovation.

Munich Re and Centene-backed digital health software provider Babylon Health is set to get a public listing through the deal.

BMW i Ventures, Dell Technologies Capital and Robert Bosch Venture Capital are in line to exit the manufactiuring services marketplace, which has filed for a $100m offering.

Noria Therapeutics and PSMA Therapeutics have both been acquired by Bayer, which will integrate their respective assets into its own oncology portfolio.

IP Group sold a $5m stake to incoming shareholder Celltrion as part of a series A round for Iksuda, a spinout of Bath originally called Glythera.

The Johnson & Johnson, GlaxoSmithKline and DaVita HealthCare Partners-backed medical device producer is looking to raise $75m in an offering on the Nasdaq Global Market.

HubSpot has exited the marketing platform developer in an acquisition by Attentive that follows some $8m of funding.

The e-commerce software provider has been acquired by CDK Global after approximately $24m in funding from investors including Liberty Mutual.

Sham Innovation Santé is set to exit the oncology diagnostics test developer in an cash-and-stock acquisition expected to close later this year.